- Home
- ARDC vs PALI Comparison
ARDC vs PALI Comparison
Compare ARDC & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARDC | PALI |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.6M | 249.2M |
| IPO Year | 2011 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARDC | PALI |
|---|---|---|
| Price | $11.23 | $1.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $9.80 |
| AVG Volume (30 Days) | 130.3K | ★ 2.6M |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $11.15 | $1.32 |
| 52 Week High | $13.99 | $2.86 |
Technical Indicators
Market Signals| Indicator | ARDC | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 28.93 | 40.38 |
| Support Level | N/A | $1.32 |
| Resistance Level | $11.51 | $2.18 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 14.28 | 25.81 |
Price Performance
Historical ComparisonAbout ARDC Ares Dynamic Credit Allocation Fund Inc.
Ares Dynamic Credit Allocation Fund Inc is a closed-end, diversified, management investment company. The Fund's investment objective is to seek an attractive risk adjusted level of total return, through current income and, secondarily, through capital appreciation. The Fund invests in a broad, dynamically managed portfolio of (i) senior secured loans, (ii) corporate bonds, (iii) other fixed-income instruments, and (iv) securities issued by entities commonly referred to as collateralized loan obligations and other asset-backed securities.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.